Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance.
- DOI
- 10.1016/j.drudis.2020.12.016
- Published
- 2020-12-25
- Container
- Drug Discov Today
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.drudis.2020.12.016,
title = {Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance.},
author = {Khot VM and Salunkhe AB and Pricl S and Bauer J and Thorat ND and Townley H.},
year = {2021},
journal = {Drug Discov Today},
doi = {10.1016/j.drudis.2020.12.016},
url = {https://doi.org/10.1016/j.drudis.2020.12.016}
}RIS
TY - JOUR TI - Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance. AU - Khot VM AU - Salunkhe AB AU - Pricl S AU - Bauer J AU - Thorat ND AU - Townley H. PY - 2021 JO - Drug Discov Today DO - 10.1016/j.drudis.2020.12.016 UR - https://doi.org/10.1016/j.drudis.2020.12.016 ER -
APA
VM, K., AB, S., S, P., J, B., ND, T., & H., T. (2021). Nanomedicine-driven molecular targeting, drug delivery, and therapeutic approaches to cancer chemoresistance.. Drug Discov Today. https://doi.org/10.1016/j.drudis.2020.12.016
Source records
- europe-pmc · retrieved 2026-09-26T07:39:46.412Z